Clinicians have been using this device to perform M-TEER for years. After this latest announcement, it is now officially approved for both mitral valve repair and tricuspid valve repair.
“Instead of asking only whether a patient will survive, we need to ask whether they will be able to maintain the life they value after discharge,” one researcher explained.
The Shockwave C2 Aero Fly Coronary IVL Catheter from Johnson & Johnson MedTech is now available. In addition, the company announced, the next-generation device will be featured in its booth at TCT 2026.
ASNC focuses on selecting the appropriate examination for each patient rather than treating one modality as universally preferable. At the same time, cardiac PET has been linked to key benefits that could improve patient care if only more clinicians could use it. ASNC's next president, Andrew Einstein, MD, PhD, discussed this and more in a new interview.
California-based Masimo received the clearance just a few months after being acquired by Danaher Corporation in a deal worth approximately $9.9 billion.
Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.
